Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus

European Journal of Gynaecological Oncology

Volumn 26, Issue 6, 2005, Pages 627-631

  Bozas, G T ^a   Bamias, A ^a,c   Kastritis, E ^a   Rodolakis, A ^a   Vlahos, G ^a   Papadimitriou, C A ^a   Markaki, S ^b   Dimopoulos, M A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Adjuvant chemotherapy; Endometrial cancer; Paclitaxel; Uterine clear cell carcinoma; Uterine papillary serous carcinoma

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIOID CARCINOMA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MYALGIA; NAUSEA AND VOMITING; NEUROTOXICITY; THROMBOCYTOPENIA; UTERUS CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 29844446045     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rose P.G.: "Endometrial Carcinoma". E. Engl. J. Med., 1996, 335, 640.
2. Slomovitz B.M., Burke T.W., Eifel P.J., Ramondetta L.M., Silva E.G., Jhingram A. et al.: "Uterine papillary serous carcinoma (UPSC): A single institution review of 129 cases". Gynecol. Oncol., 2003, 91, 463.
3. Trope C., Kristensen G.B., Abeler V.M.: "Clear-cell and papillary serous cancer: treatment options". Best Pract. Res. Clin. Obstet. Gynecol., 2001, 15, 433.
4. Cirisano F.D., Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S. et al.: "The outcome of Stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma". Gynecol. Oncol., 2000, 77, 55.
5. Christopherson W.N., Alberhasky R.C., J.C.P.: "Carcinoma of the endometrium. A clinicopathological study of clear cell carcinoma and secretory carcinoma". Cancer, 1982, 49, 1511.
6. Hendrickson M.R., Ross J., Eifel P.J., Martinez A., Kempson R.: "Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma". Am. J. Surg. Pathol., 1982, 6, 93.
7. Abeler V.M., Vergote I.B., Kjorstad K.E., Trope C.G.: "Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern". Cancer, 1996, 78, 1740.
8. Cirisano F.D., Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S. et al.: "Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma". Gynecol. Oncol., 1999, 74, 385.
9. Goff B.A., Kato D., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G., et al.: "Uterine papillary serous carcinoma: patterns of metastatic spread". Gynecol. Oncol., 1994, 54, 264.
10. Carcangiu M.L., Chambers J.T.: "Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival". Int. J. Gynecol., 1995, 14, 30.
11. Sherman M.E., Bitterman P., Rosenshein N.B., Delgado G., Kurman R.J.: "Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features". Am. J. Surg. Pathol., 1992, 16, 600.
12. Sood B.M., Jones J., Gupta S., Khabele D., Guha C., Runowicz C. et al.: "Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma". Int. J. Rad. Oncol. Biol. Phys., 2003, 57, 208.
13. Kato D.T., Ferry J.A., Goodman A., Sullinger J., Scully R.E., Goff B.A. et al.: "Uterine papillary serous carcinoma (UPSC): A clinicopathologic study of 30 cases". Gynecol. Oncol., 1995, 59, 384.
14. Burke T.W., Gershenson D.M., Morris M., Stringer A., Levenback C., Tortolero-Luna G. et al.: "Postoperative adjuvant cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma". Gynecol. Oncol., 1994, 55, 47.
15. Price F.V., Chambers S.K., Carcangiu M.L., Kohorn E.I., Schwartz P.E., Chambers J.T.: "Intravenous cisplatin, doxorubicin and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)". Gynecol. Oncol., 1993, 51, 383.
16. Stringer C.A., Gershenson D.M., Burke T.W., Edwards C.L., Gordon A.N., Wharton J.T.: "Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis". Gynecol. Oncol., 1990, 38, 305.
17. Levenback C., Burke T.W., Silva E., Morris M., Gershenson D.M., Kavanagh J.J. et al.: "Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)". Gynecol. Oncol., 1992, 46, 317.
18. Chambers J.T., Chambers S.K., Kohorn E.I., Carcangiu M.L., Schwartz P.E.: "Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide". Gynecol. Oncol., 1996, 60, 438.
19. Rowinsky E.K., Donehower R.C.: "Paclitaxel (Taxol)". New Engl. J. Med., 1995, 332, 1004.
20. Lincoln S., Blessing J.A., Lee R.B., Rocerto T.F.: "Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study". Gynecol. Oncol., 2003, 88, 277.
21. Ball H.G., Blessing J.A., Lentz S.S., Mutch D.G.: "A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study". Gynecol. Oncol., 1996, 62, 278.
22. Fleming G.F., Brunetto V.L., Cella D., Look K.Y., Reid G.C., Munkarah A.R. et al.: "Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study". J. Clin. Oncol., 2004, 22, 2159.
23. Hirai Y., Hasumi K., Onose R., Kuramoto H., Kuzuya K., Hatae M. et al.: "Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group". Gynecol. Oncol., 2004, 94, 471.
24. Hoskins P.J., Swenerton K.D., Pike J.A., Wong F., Lim P., Aquino-Parsons C. et al.: "Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study". J. Clin. Oncol., 2001, 19, 4048.
25. Calvert A., Newel D., La G. et al.: "Carboplatin dosage: Prospective evaluation of a simple formula based on renal function". J. Clin. Oncol., 1989, 7, 1748.
26. Matthews R.P., Hutchinson-Colas J., Maiman M., Fruchter R.G., Gates E.J., Gibbon D. et al.: "Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women". Gynecol. Oncol., 1997, 65, 206.
27. Craighead P.S., Sait K., Stuart G.C., Arthur K., Nation J., Duggan M. et al.: "Management of aggressive histologic variants of endometrial carcinoma at the tom baker cancer centre between 1984 and 1994". Gynecol. Oncol., 1999, 77, 248.
28. 192Ir) and chemotherapy". Int. J. Rad. Oncol. Biol. Physics, 1998, 40, 77.
29. Huh W.K., Powell M., Leath C.A., Straughn M.J., Cohn D.E., Gold M.A. et al.: "Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy". Gynecol. Oncol., 2003, 91, 470.
30. Bristow R.E., Asrari F., Trimble E.L., Montz F.J.: "Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease". Gynecol. Oncol., 2001, 81, 279.
31. Bancher-Todesca D., Neunteufel W., Williams K.E., Prainsack D., Breitenecker G., Friedlander M.L. et al.: "Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma". Gynecol. Oncol., 1998, 71, 344.
32. Hamaguchi K., Komai K., Sakihama H., Okura N., Nagasue N., Nishida T. et al.: "Chemotherapeutic approach to uterine papillary serous carcinoma". Asia Oceania J. Obstet. Gynaecol., 1990, 16, 367.
33. Ramondetta L., Burke T.W., Levenback C., Bevers M., Bodurka-Bevers D., Gershenson D.M.: "Treatment of uterine papillary serous carcinoma with paclitaxel". Gynecol. Oncol., 2001, 82, 156.
34. Zanotti K.M., Belinson J.L., Kennedy A.W., Webster K.D., Markman M.: "The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma". Gynecol. Oncol., 1999, 74, 272.
35. Price F.V., Amin R.M., Sumkin J.: "Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma". Gynecol. Oncol., 1999, 73, 140.
36. Thuan L.D., Yamada D., Rutgers J.L., DiSaia P.J.: "Complete response of a Stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin". Gynecol. Oncol., 1999, 73, 461.
37. Aoki Y., Watanabe M., Amikura T., Obata H., Sekine M., Yahata T. et al.: "Adjuvant chemotherapy as treatment of high-risk Stage I and II endometrial cancer". Gynecol. Oncol., 2004, 94, 333.
38. Smith R.S., Kapp D.S., Chen Q., Teng N.N.H.: "Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy". Int. J. Rad. Oncol. Biol. Phys., 2000, 48, 767.
39. Martinez A.A., Weiner S., Podratz K., Armin A.R., Stromberg J.S., Stanhope R. et al.: "Improved outcome at 10 years for serous-papillary/ clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation". Gynecol. Oncol., 2003, 90, 537.
40. Mehta N., Yamada D., Rotmensch J., Mundt A.J.: "Outcome and patterns of failure in pathologic Stage I-II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy". Int. J. Rad. Oncol. Biol. Phys., 2003, 57, 1004.
41. Grice J., Ek M., Greer B., Koh W.-J., Muntz H.G., Cain J. et al.: "Uterine papillary serous carcinoma: Evaluation of long-term survival in surgically staged patients". Gynecol. Oncol., 1998, 69, 69.